Development of vaccines against Ornithodoros soft ticks: an update by Díaz Martín, Verónica et al.
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
1 
1 
1
Title. 2
Development of vaccines against Ornithodoros soft ticks: an update. 3
4
Authors 5
Verónica Díaz-Martína, Raúl Manzano-Romána, Prosper Oboloa, Ana Oleagaa, Ricardo Pérez-6
Sáncheza,*.7
8
9
uthor’saffiliations:10
a Parasitología Animal, Instituto de Recursos Naturales y Agrobiología de Salamanca (IRNASA, 11
CSIC), Cordel de Merinas, 40-52, 37008 Salamanca, Spain.12
13
uthor’se-mail address: 14
veronica.diaz@irnasa.csic.es; raul.manzano@irnasa.csic.es; 15
prosper.obolo@irnasa.csic.es; ana.oleaga@irnasa.csic.es;  16
ricardo.perez@irnasa.csic.es17
18
19
* Corresponding author:  20
Ricardo Pérez-Sánchez 21
Parasitología Animal, IRNASA, CSIC,  22
Cordel de Merinas, 40-52, 37008 Salamanca, Spain.  23
Tel.: +34 923219606; 24
fax: +34 923219609. 25
e-mail address: ricardo.perez@irnasa.csic.es26
27
28
*Manuscript R1
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
2 
2 
Abstract. 29
Ticks are parasites of great medical and veterinary importance since they are vectors 30
of numerous pathogens that affect humans, livestock and pets. Among the argasids, several 31
species of the genus Ornithodoros transmit serious diseases such as tick-borne human 32
relapsing fever (TBRF) and African Swine Fever (ASF). In particular, Ornithodoros erraticus is 33
the main vector of these two diseases in the Mediterranean while O. moubata is the main 34
vector in Africa. The presence of these Ornithodoros ticks in domestic and peridomestic 35
environments may greatly hinder the eradication of TBRF and ASF from endemic areas. In 36
addition, there is a constant threat of reintroduction and spreading of ASF into countries from 37
where it has been eradicated (Spain and Portugal) or where it was never present (the 38
Caucasus, Russia and Eastern Europe). In these countries, the presence of Ornithodoros vectors 39
could have a tremendous impact on ASF transmission and long-term maintenance. Therefore, 40
elimination of these ticks from at least synanthropic environments would contribute heavily to 41
the prevention and control of the diseases they transmit. Tick control is a difficult task and 42
although several methods for such control have been used, none of them has been fully 43
effective against all ticks and the problems they cause. Nevertheless, immunological control 44
using anti-tick vaccines offers an attractive alternative to the traditional use of acaricides. The 45
aim of the present paper is to offer a brief overview of the current status in control measure 46
development for Ornithodoros soft ticks, paying special attention to the development of 47
vaccines against O. erraticus and O. moubata. Thus, our contribution includes an analysis of 48
the chief attributes that the ideal antigens for an anti-tick vaccine should have, an exhaustive 49
compilation and analysis of the scant anti-soft tick vaccine trials carried out to date using both 50
concealed and salivary antigens and, finally, a brief description of the new reverse vaccinology 51
approaches currently used to identify new and more effective protective tick antigens. 52
53
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58
Introduction59
Ticks are cosmopolitan blood-sucking ectoparasites of mammals, birds and reptiles. 60
Ticks belong to two main families, the Argasidae (soft ticks) and the Ixodidae (hard ticks), 61
which share common basic properties but differ in their morphology, biology and ecology. A 62
monotypic third tick family is Nuttalliellidae, whose sole species (Nuttalliella namaqua) 63
possesses features of soft and hard ticks and is considered the missing link between the main 64
two families (Hoogstraal, 1985; Latif et al., 2012; Manzano-Román et al., 2012a). 65
Typically, ixodids are exophilic ticks that remain on the soil and vegetation and actively 66
seek hosts when the season is suitable. After attachment to an adequate host they feed for 67
several days, ingesting enormous amounts of blood and once engorged they then drop off the 68
host returning to the soil, where they moult or, in the case of females, oviposit and die. By 69
contrast, argasid ticks tend to be endophilic/nidicolous parasites. In the natural environment 70
they live inside the nests and burrows of their hosts and in synanthropic environments they 71
colonize animal facilities and human dwellings, where they remain protected from adverse 72
climatic conditions and have regular access to host blood. Most argasids are fast feeders (they 73
feed in less than one hour) ingesting a relatively small amount of blood per meal and adult 74
specimens can feed and reproduce repeatedly. Argasids are very resistant to starvation and 75
can even survive for several years without feeding (Mans and Neitz, 2004; Oleaga et al., 1990; 76
Sonenshine, 1992; Vial, 2009). 77
Ticks are parasites of great medical and veterinary importance because they are the 78
vectors of numerous pathogens including viruses, bacteria, protozoa and helminths, all of 79
which affect humans, livestock and pets (de la Fuente et al., 2008; Jones et al., 2008). In 80
addition, their feeding can cause direct damage to their hosts such as significant blood loss, 81
paralysis, toxicosis, irritation, allergy and tissue destruction (Jongejan & Uilenberg, 2004). 82
Regarding the pathogens transmitted by argasids, these are mainly viruses and 83
bacteria. Among the currently recognized viral diseases transmitted by soft ticks, African Swine 84
Fever (ASF) is particularly important. In addition, most of the bacteria transmitted by argasids 85
are Borrelia species that cause relapsing fever in humans (Manzano-Román et al., 2012a). 86
There are two types of human relapsing fever: the epidemic or louse-borne type, 87
caused by Borrelia recurrentis and transmitted by the human body louse Pediculus humanus, 88
and the endemic or tick-borne (TBRF) type caused by many different Borrelia species, which 89
are all of them transmitted by soft ticks of the genus Ornithodoros. TBRF is characterized by 90
episodes of recurring fever and non-specific symptoms such as headache, myalgia, arthralgia, 91
chills and abdominal pains. TBRF is highly endemic in some east African countries, namely 92
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Tanzania, where it affects the 6.4% of population and is responsible for up to 436 per 1,000 93
perinatal mortality rates. In Eurasia and the Americas TBRF is more sporadic affecting mainly 94
humans who enter caves, ruins, or animal shelters infested with soft ticks (Cutler, 2006, 2010; 95
Diatta et al., 2012; Rebaudet and Parola, 2006). 96
ASF is caused by the African swine fever virus (ASFV), which is the only known DNA 97
virus with an arthropod vector (Penrith et al., 2013). ASF is a haemorrhagic fever disease of 98
pigs with mortality rates approaching 100 %. It causes major economic losses, threatens food 99
security and limits pork production in affected countries. The disease was originally confined 100
to Africa until it spread to Europe in the middle of the last century and later also to South 101
America and the Caribbean. In Europe (except Sardinia) and the Americas the infection was 102
eradicated via drastic control and eradication programs. However, in 2007 the disease was 103
introduced into Georgia, from where it rapidly spread to neighbouring Trans-Caucasian 104
countries, the Russian Federation and Eastern Europe, and then recently into the European 105
Union (OIE WAHID, visited December 4th 2014). There is no vaccine against ASFV and this limits 106
the options for disease control (Costard et al., 2013; Sanchez-Vizcaíno et al., 2012, 2015). 107
As mentioned above, these two diseases -TBRF and ASF- are transmitted by soft tick 108
species of the genus Ornithodoros. In particular, O. moubata is their main vector in Africa and 109
O. erraticus is their main vector in the Mediterranean Basin (Costard et al., 2013; Cutler, 2010). 110
Moreover, O. erraticus is the type species of the O. erraticus complex, which includes among 111
others several species such as O. alactagalis, O. asperus, O. pavlovskyi, O. tartakovskyi, O. 112
tholozani and O. lahorensis. These species are distributed throughout the Middle East, the 113
Caucasus and the Russian Federation, where ASF is currently spreading. Although not yet 114
experimentally proved, these species are suspected to be competent vectors for ASFV; should 115
this be the case, they could have a tremendous impact on the transmission and long-term 116
maintenance of ASF in this broad region (EFSA panel, 2010a, 2010b, 2010c). 117
The presence of Ornithodoros ticks in domestic and peridomestic environments is an 118
enormous pitfall in the eradication of TBRF and ASF from endemic areas. In addition, the  119
presence of Ornithodoros populations also worsens the constant threat of reintroduction, 120
spreading and maintenance of ASF into countries from where it has been eradicated, such as 121
Spain and Portugal, or where it was never present (Boinas et al., 2014; Costard et al., 2013; 122
Sanchez-Vizcaíno et al., 2012, 2015; Wilson et al., 2013). Accordingly, elimination of these ticks 123
from at least synanthropic environments would be of great help in the prevention and control 124
of the diseases they transmit. 125
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The aim of the present paper is to offer a brief overview of the current status in 126
control measure development for Ornithodoros soft ticks, paying special attention to 127
development of vaccines against O. erraticus and O. moubata. 128
129
Methods for tick control. 130
Control of tick infestations and tick-produced damages represent a multifaceted 131
problem that remains unsolved since none of the control methods applied to date has been 132
fully effective against all ticks (Manzano-Román et al., 2012a). The control of tick populations 133
has been essentially based on the use of chemical acaricides (arsenicals, chlorinated 134
hydrocarbons, organophosphates, carbamates and synthetic pyrethroids). However, these 135
products have severe drawbacks such as environmental pollution, the contamination of animal 136
products and the selection of resistant tick strains, which greatly reduces the usefulness and 137
average useful life of the agent on the market (George et al., 2008; Ghosh et al., 2007; Graf et 138
al., 2004; Guerrero et al., 2012). In addition, the use of acaricides against Ornithodoros ticks is 139
inefficient because of their nidicolous/endophilic lifestyle, which means that it is not possible 140
to ensure that these agents will reach all places where these parasites hide (Astigarraga et al., 141
1995).  142
The problems associated with the use of acaricides together with the high costs 143
involved in the development and commercialization of new chemical agents (Guerrero et al., 144
2012) have encouraged the quest for alternative methods for tick control, including anti-tick 145
vaccines and bio-control with agents such as parasitoids, predators and entomopathogenic 146
organisms, mostly fungi, bacteria and nematodes (Samish et al., 2008). 147
Among these bio-control agents, the only ones tested against soft ticks to date have 148
been entomopathogenic fungi (Samish et al., 2008). These organisms, and particularly the 149
species Beauveria bassiana and Metarhizium anisopliae, have been shown to be effective 150
against ticks in several laboratory and field studies (Fernandes and Bittencourt, 2008; Ment et 151
al., 2013; Polar et al., 2008; Ren et al., 2014). However, such studies have focused almost 152
exclusively on the control of ixodid ticks and have neglected argasid ticks. There are some 153
exceptions to this rule, such as the works of Sewify and Habib (2001) and Habib and Sewify 154
(2002), who studied the pathogenic effect of M. anisopliae and B. bassiana on Argas persicuss. 155
These authors sprayed heavily infested poultry houses with fungal spore suspensions and 156
observed that the argasid population disappeared in 3 weeks. There is also the work of 157
Pourseyed et al. (2010), who obtained up to 100 % mortality in larvae and females of Argas 158
persicus treated with M. anisopliae under laboratory conditions. Finally, also interesting are 159
the works of Zabalgogeazcoa et al. (2008) and Herrero et al. (2011), who carried out laboratory 160
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trials showing that several isolates of B. bassiana and Tolypocladium cylindrosporum caused up 161
to 70 % mortality in O. erraticus and up to 40 % mortality in O. moubata. Therefore, further 162
investigations for developing entomopathogenic fungal strains as anti-argasid biocontrol 163
agents seems to be justified (Manzano-Román et al., 2012a). 164
Immunological control using anti-tick vaccines offers an even more attractive method 165
than entomopathogenic fungi for replacing and/or supplementing the use of chemical 166
acaricides. The last decade of the twentieth century saw the advent of the first two 167
commercial anti-tick vaccines (TickGARD© in Australia and GAVAC© in Latin America). Both 168
vaccines were directed towards the ixodid tick Rhipicephalus microplus and were based on the 169
antigen Bm86, which is a glycoprotein expressed on the luminal membrane of midgut 170
epithelial cells, hidden from the host’s immune system and consequently considered a 171
concealed antigen (Willadsen et al., 2008). 172
Although with variable efficacy, the application of these two vaccines during the last 173
two decades has shown that host vaccination is a suitable and sustainable method for the 174
control of tick populations. The implementation of anti-tick vaccines in integrated control 175
programmes permits a reduction in the use of acaricides, which in turn decreases treatment 176
costs. Reduced acaricide use also decreases the likelihood of acaricide resistance development, 177
thus prolonging the average commercial life of acaricide agents (de la Fuente et al., 2007; 178
Guerrero et al., 2012; Vargas et al., 2010; Willadsen, 2008). 179
Despite this success and the ensuing intensive investigation carried out in this field 180
during the last twenty years (especially in ixodid ticks), the development of new and more 181
effective anti-tick vaccines has been slower than expected and no new anti-tick vaccine has yet 182
been commercialized. Several economic reasons have contributed to this delay but the main 183
reason has been the difficulty involved in identifying new and highly protective tick antigens 184
(Guerrero et al., 2012; Willadsen, 2008). 185
As a result, at present there is only a limited repertoire of vaccine candidate antigens 186
and these come mostly from hard ticks (Guerrero et al., 2012; Merino et al., 2013; Parizi et al., 187
2012; Willadsen, 2008). Regarding soft ticks, the number of candidate antigens for vaccine 188
development is even lower than for hard ticks. Thus, there is an urgent need to identify new 189
tick protective antigens to increase the chance of developing successful anti-tick vaccines. 190
191
Desirable attributes in candidate antigens for the development of anti-tick vaccines. 192
There is a fair degree of consensus regarding the main attributes that an ideal antigen 193
for an anti-tick vaccine must have (de la Fuente et al., 2011; de la Fuente, 2012; Flower et al., 194
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2010; Guerrero et al., 2012; Maritz-Olivier et al., 2012; Moreno-Cid et al., 2013; Parizi et al., 195
2012; Wikel, 2013). These attributes would be as follows.  196
First, the target antigen must be easily accessible to the host immune effectors (i.e., 197
antibodies) ingested during blood feeding. Accordingly, secreted salivary proteins (exposed 198
antigens) and membrane proteins expressed on the luminal surface of midgut cells (concealed 199
antigens) could be suitable candidate antigens. In addition, since host immunoglobulins can 200
pass from the gut lumen to the haemolymph (Chinzei and Minoura, 1988; Nuttall et al., 2006) 201
other concealed antigens from internal organs bathed by haemolymph would also be suitable. 202
Salivary exposed antigens seems quite attractive since these antigens elicit an immune 203
response during tick infestations, and a vaccine based on such antigens would prime a 204
vaccinated animal’s immune response against tick infestation However some authors have 205
expressed some reserve regarding salivary exposed antigens since the co-evolution of the tick-206
host interaction has likely led to the development by ticks of means to circumvent the host 207
immune system’s response to exposed antigens (Brake and Pérez de León, 2012). In this sense, 208
“silent” salivary antigens might be more adequate because are not subjected to selective 209
pressure by the host immune system and ticks would have not evolved mechanisms to protect 210
them. These would include all the tick secreted salivary antigens that are not recognized by 211
host immunity upon repeated exposure to ticks, but that can be recognized by a vaccine-212
induced response, as was observed for the Ixodes scapularis sialostatin L2 (Kotsyfakis et al., 213
2008). This type of antigen would allow the development of dual-action vaccines, in which tick 214
infestations on vaccinated animals would act as boosting antigen doses (Trimnell et al., 2002).  215
Second, the antigen should have a critical function in the tick such that the disruption 216
of that function would lead either to lethality or reduced fecundity at levels that impact the 217
tick population. 218
Third, it would be also desirable candidate antigens encoded by unigenes or by low 219
copy-number genes not included in any family. The aim is to prevent redundant family 220
members from taking up the function of the targeted member and favour specific blockage of 221
crucial functions in ticks. 222
Fourth, the antigen should share conserved epitopes among several tick species and, 223
ideally, among other arthropod vectors to protect against multiple vector infestations. 224
Finally, it would be also very appropriate that the protective antigen could reduce the 225
vector capacity for the transmission of vector-borne pathogens. 226
None of the candidates currently available fulfil all these requirements and the most 227
effective ones meet only two or three criteria. For example, the Bm86 glycoprotein and the 228
subolesin/akirin orthologues are both examples of concealed antigens; they are also highly 229
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conserved in different tick species, and they also reduce vector capacity for the transmission of 230
pathogens (de la Fuente et al., 2011). 231
Taking the above-mentioned concepts into consideration, a number of current 232
research programs are prioritizing the identification of membrane-associated or membrane-233
bound antigens that are expressed in the midgut or ovary and that share cross-reacting 234
epitopes (due to sequence similarity) with proteins secreted into the saliva. These antigens 235
would be the basis for dual-action vaccines and these vaccines are considered to be the most 236
promising ones (Guerrero et al., 2012). The primary example of this kind of cross-reacting dual 237
action antigen is the Rhipicephalus appendiculatus cement antigen 64TRP (Trimnel et al., 2002, 238
2005). A second example of potential dual-action antigen would be the R. microplus antigen 2, 239
which is a gut antigen sharing sequence similarity to a secreted homolog in salivary glands 240
(Guerrero et al., 2012; Rachinsky et al., 2008). This antigen may be a dual action candidate 241
since it may elicit cross-protective antibodies that might recognize the salivary homolog as well 242
due to conserved epitopes. 243
Consistent with the above priority, the gut transcriptomes and proteomes from some 244
ixodid ticks have begun to be analysed, and those from Dermacentor variabilis (Anderson et 245
al., 2008) and R. microplus (Heekin et al. 2013; Kongsuwan et al. 2010; Popara et al., 2013; 246
Rachinsky et al., 2008) have recently been published. Regarding argasid ticks, no gut 247
transcriptome or proteome has been published to date, although the sialomes from four 248
species of this family are already available (Díaz-Martín et al., 2013a; Francischetti et al. 2009), 249
and this may serve as a reference in the search for antigens for dual-action vaccines.250
251
Update on the development of vaccines against ornithodoros soft ticks.  252
To date, studies aimed at developing vaccines against soft ticks have been notably less 253
abundant than the focused on hard ticks and have addressed just a few species belonging to 254
the genera Ornithodoros and Argas (Table 1). Regarding Argas sp., the studies available include 255
the work of Dusbábek et al. (1990) on Argas polonicus and the works of Sayed et al. (2001, 256
2004) on Argas persicus. Regarding Ornithodoros sp., the studies available are the work of 257
Chinzei and Minoura (1988) and Salat et al. (2010) on O. moubata, the work of Need and 258
Butler (1991) on Ornithodoros turicata and Ornithodoros talaje, and the studies carried out by 259
our own team on O. erraticus and O. moubata. In these contributions, the protective efficacy 260
of both salivary and concealed antigens has been examined. 261
Concealed antigens. 262
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
9 
9 
The first study with this type of antigen in soft ticks was performed by Chinzei and 263
Minoura (1988), who immunized rabbits with egg vitellin and obtained a protective response 264
that reduced female fecundity by 50 %. Most likely, the protective mechanism would have 265
been exerted by host antibodies specific to vitellin/vitellogenin passing from the tick midgut 266
lumen to the haemolymph, where they would have bound to haemolymph-borne vitellogenin 267
thus blocking vitellogenin uptake by oocytes in the ovary (Ben-Yakir, 1989; Chinzei and 268
Minoura, 1988; Gudderra et al., 2002; Horigane et al., 2010; Kopacek et al., 2000). 269
Soon after, Need and Butler (1991) immunized CD1 mice with protein extracts from 270
midgut and from the remaining internal organs obtained from both O. turicata and O. talaje271
ticks. The larvae of these two species were allowed to feed on vaccinated mice and while no 272
effect on the larvae of O. turicata was observed, the larvae of O. talaje had an increased 273
mortality rate of up to 29 %. Since host antibodies (mainly IgG1) were detected in the 274
haemolymph of the larvae of both species, the authors attributed the protective response 275
against the long feeding O. talaje larvae to cellular immune effectors. Although this 276
observation is correct, the role of antibodies in conferring protection should not be 277
underestimated. Protection may have been associated to higher antibody quality (affinity vs. 278
avidity) instead to higher antibody titre (Vidarsson et al., 2014) or higher antibody exposition 279
as a consequence of prolonged feeding behaviour. Moreover, protection could have been 280
greatly determined by the particular epitopes (protective or not) that were actually presented 281
and recognized by the host immune system in each antigen preparation. A real example of this 282
is commented below (Manzano-Román et al., 2015). 283
In 1995, our group began the studies on soft-tick concealed antigens by immunizing 284
pigs with soluble extracts of haemolymph, synganglion, coxal glands and midgut from O. 285
erraticus (Astigarraga et al., 1995). In these experiments, we did not observe any adverse 286
effect on O. erraticus specimens fed on the vaccinated animals. The lack of protection was 287
attributed to the unwanted removal of the membrane proteins from the antigenic extracts 288
during their preparation procedure since, according to the criteria described before, 289
membrane proteins (and particularly those expressed on the luminal surface of enterocytes) 290
would have been the most adequate vaccine candidates. 291
Subsequently, Manzano-Román (2002) confirmed the above-mentioned hypothesis as 292
he observed the following. Extracts of membrane proteins from the midgut epithelial cells of 293
O. erraticus induced protective responses in pigs, rabbits and mice that reduced females 294
feeding and fecundity by up to 50 % and, additionally, caused up to 80 % mortality in nymphs 295
fed on vaccinated animals during the first 72 hours post-feeding. The antigen responsible for 296
protection was a 45 kDa protein (Oe45) expressed on the luminal surface of midgut epithelial 297
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cells between 24 and 72 hours post-feeding. The protective mechanism involved the fixation 298
and activation of the host complement system onto the membrane of enterocytes by anti-299
Oe45 antibodies. This caused enterocyte lysis and midgut damage in a similar way to what was 300
observed for the commercial anti-tick vaccines based on the Bm86 antigen (Manzano-Román 301
et al., 2006, 2007). 302
The high level of protection achieved with the enterocyte membrane antigens of O. 303
erraticus encouraged us to test the protective potential of a similar antigenic extract from O. 304
moubata (García Varas, 2004). With this species, the protective effect was lower and 305
essentially consisted of a 40 % decrease in feeding and reproduction without affecting tick 306
survival. At the time, the absence of tick lethality was attributed to the fact that O. moubata307
secretes coxal fluid while it is still feeding whereas O. erraticus does so after detachment.  308
Accordingly, in O. moubata the ingested blood could reach the midgut ceca in a sufficiently 309
concentrated form to prevent antibodies and complement factors from diffusing to the 310
luminal surface of the enterocytes and reaching their target antigen (García Varas, 2004). 311
Finally, in two recent studies our team investigated the protective value of the O. 312
erraticus and O. moubata subolesin orthologues. Subolesin was first discovered as a protective 313
antigen in Ixodes scapularis (Almazán et al., 2003). Later, it was demonstrated that subolesin is 314
an orthologue of insect and vertebrate akirins, which are evolutionarily conserved proteins 315
that function as transcription factors in the regulation of gene expression thus affecting 316
numerous processes such as feeding, fertility and tissue development (Galindo et al., 2009; 317
Goto et al., 2008). Moreover, subolesin was found to be functionally involved in innate tick 318
immunity to pathogens and in the infection and multiplication of some pathogens such as 319
Anaplasma phagocytophilum, A. marginale, Babesia bigemina and Borrelia burgdorferi (de la 320
Fuente et al., 2013). Subolesin gene knockdown by RNAi and vaccination with recombinant 321
subolesin/akirin has a profound effect on tick infestations reducing tick numbers, weight and 322
oviposition, as well as on tick infection with different tick-borne pathogens. Additionally, 323
subolesin/akirin orthologues share common structural and protective epitopes in different 324
arthropod vector species including hard ticks, mosquitoes, sand flies, poultry red mites and sea 325
lice. This highlights the potential of subolesin/akirin-based vaccines for the control of vectors 326
and vector-borne pathogens (de la Fuente et al., 2011, 2013; Moreno-Cid et al., 2013). 327
Regarding the protective value of subolesin against soft ticks, we observed that 328
knocking down the subolesin gene orthologues in O. erraticus and O. moubata by RNAi 329
inhibited tick oviposition by more than 90 % without affecting tick feeding and survival. 330
However, vaccination with the corresponding recombinant proteins induced robust but low 331
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protective humoral responses (5 % - 24.5 % reduction in oviposition) (Manzano-Román et al., 332
2012b). 333
Trying to explain the reason for this low degree of protection, it was later observed 334
that vaccination with whole subolesin recombinants induced non-protective antibodies mainly 335
directed to immunodominant linear B-cell epitopes located on highly structured regions of the 336
subolesin protein. Structured regions are likely unrelated to the subolesin biological activity, 337
while the unstructured/disordered regions of the protein, which are assumed to contain the 338
functional site, were not recognized by the vaccine-induced antibodies. Subsequently, four 339
synthetic peptides from the unrecognized/disordered regions of the Ornithodoros subolesin 340
sequences were designed, synthesized and coupled to keyhole limpet haemocyanin (KLH). 341
Vaccination with KLH-peptide conjugates induced the synthesis of specific antibodies that 342
recognized linear B-cell epitopes located on the unstructured loops of the subolesin proteins 343
and provided up to 70.1 % and 83.1 % vaccine efficacies against O. erraticus and O. moubata, 344
respectively (Manzano-Román et al., 2015). These results demonstrated that the protective 345
effect of subolesin-based vaccines was highly dependent on the particular epitope being 346
recognized by antibodies and strongly suggest that the biological activity of subolesin is 347
exerted through its unstructured regions, in accordance with recent findings by de la Fuente et 348
al. (2013), Merino et al. (2013) and Moreno-Cid et al. (2013). 349
Overall, these results contribute to our understanding of the mechanism of protection 350
of subolesin-based vaccines. They point to additional protective peptides for inclusion in the 351
array of candidate antigens and expand the range of target organisms for subolesin/akirin-352
based vaccines against soft ticks. 353
Salivary antigens. 354
In general, the few vaccine trials performed to date with salivary antigens have 355
reported highly variable protection efficacies. Need and Butler (1991) reported 16 % mortality 356
in O. talaje larvae fed on CD1 mice vaccinated with a salivary gland extract (SGE) from that 357
species, similar to the mortality rate observed in mice immunized by natural contact. More 358
recently, Salat et al. (2010) evaluated the protective potential of recombinant OmC2 cystatin 359
from O. moubata in C3H/HeN mice and found 15 % increase in mortality and 39 % reduction in 360
the feeding of O. moubata nymphs-1 fed on vaccinated mice. 361
Regarding the studies on soft tick salivary antigens carried out by our team, these were 362
begun by vaccinating pigs with SGE obtained from O. erraticus and O. moubata (Astigarraga et 363
al., 1995).  364
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Vaccination with O. erraticus SGE induced highly variable protective responses, the 365
best of them attaining a 50 % reduction in the feeding and fecundity of females. These results 366
clearly showed that at least in O. erraticus it was possible to induce protective responses using 367
salivary antigens. The protection was associated to several silent antigens of the SGE (namely, 368
three proteins of 70, 50 and 20 kDa) that were specifically recognized by the humoral immune 369
response of the SGE-vaccinated pigs but not recognized by the humoral response of 370
unprotected pigs sensitised by natural parasite contact (Astigarraga et al., 1995). 371
Subsequently, to identify antigens able to induce uniform humoral protective responses, 372
Manzano-Román (2002) purified these three proteins from the SGE and tested them 373
individually in new vaccine trials. All pigs vaccinated with either the 70 kDa or 50 kDa antigens 374
developed antibody responses that specifically recognized the inducing antigen. However, 375
these responses did not protect precluding the usefulness of these antigens as vaccine 376
candidates. By contrast, only a part of all the pigs vaccinated with the 20 kDa antigen were 377
able to develop a specific antibody response to it. This response was protective and reduced 378
female feeding and subsequently female fertility by up to 50 %. However, most pigs vaccinated 379
with the 20 kDa antigen were unable to develop a detectable antibody response to this 380
antigen (regardless of the dose, the adjuvant used or the mode of administration) and none of 381
these pigs were protected. From these observations it was concluded that protection can be 382
achieved after the antibody-mediated neutralization of a particular silent salivary antigen (such 383
that of 20 kDa). This antigen seems to be strongly protected from being recognized by the host 384
immune system, as suggested by the difficulties encountered in inducing humoral responses to 385
it in all the vaccinated animals thus limiting its efficacy as vaccine candidate (Manzano-Román, 386
2002). The disadvantages and limitations of these three salivary antigens avoided further 387
sequence and functional characterization. Thus, their sequences and functions as well as how 388
the 20 kDa antigen evades its recognition by the immune system remain unknown. 389
Regarding O. moubata, pig vaccination with SGE induced very homogeneous protective 390
responses causing 60 % to 70 % reductions in adult tick feeding and female oviposition. All 391
vaccinated animals recognized a protein of 44 kDa (hence the name Om44), which was never 392
recognized by the host immune system during natural parasite contact (Astigarraga et al., 393
1995). 394
Subsequent studies revealed that purified Om44 induced in pigs and rabbits a 395
protective response that inhibited tick feeding by up to 54 % and the protective effect 396
increased with successive O. moubata infestations (García-Varas et al., 2010). Thus, Om44 397
must be a silent salivary antigen according to the concept introduced by Kotsyfakis et al. 398
(2008). Functional characterization of Om44 showed that it is an antagonist ligand of host P-399
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selectin. Accordingly, Om44 probably inhibits the host haemostatic and inflammatory response 400
triggered at the tick bite lesion by the interaction between P-selectin on activated endothelial 401
cells and platelets and its receptor on leucocytes, the PSLG-1 molecule (Cleator et al., 2006; 402
García-Varas et al., 2010). Since this response could prevent tick feeding, blocking the P-403
selectin/PSGL-1 interaction at the tick bite site seems to be critical for O. moubata to complete 404
its feeding. These results represented the first evidence of a new anti-haemostatic mechanism 405
of hematophagous vectors and led Om44 to be assigned the place of an important candidate 406
for vaccine development. 407
The identification of Om44 was repeatedly attempted by mass spectrometry without 408
success. Mass spectrometric data clearly showed that Om44 was not an orthologue of already 409
established P-selectin ligands including PSGL-1 and pentraxin 3. However, the results of some 410
of the analyses performed suggested that Om44 could be an isoform of enolase (García-Varas 411
et al., 2010; Perez-Sánchez et al., 2010). Since significant amounts of secreted enolase had 412
been found in the saliva of O. moubata ticks (Díaz-Martín et al. 2013a), this protein was cloned 413
and functionally characterized. The results of this study showed that secreted salivary enolase 414
acts as a profibrinolytic receptor of host plasminogen confirming that it was not the identity of 415
Om44. Additionally, vaccination of rabbits with recombinant enolase induced partial protective 416
responses (18 % reduction in oviposition and up to 20 % nymphal mortality) differed from 417
those induced by Om44 (Díaz-Martín et al. 2013b). 418
In order to identify Om44, more recently self-assembled protein microarrays from an 419
O. moubata salivary gland expression library were screened using P-selectin and anti-Om44 420
polyclonal serum as probes. The results of these experiments indicated that Om44 was a 421
salivary secreted phospholipase A2 (GenBank KC908103.1) that binds to P-selectin through 422
protein-protein interactions without the involvement of glycan moieties (Díaz-Martín, 2014; 423
Manzano-Román et al., 2012c). 424
Moreover, random sequencing of the above expression library allowed us to identify 425
two additional anti-haemostatic salivary proteins of O. moubata, in particular an apyrase 426
(GenBank KC908110.1) and a disaggregin (named as mougrin) that is orthologous to the 427
savignyigrin of O. savignyi (GenBank KC908105.1). Vaccination of rabbits with the recombinant 428
forms of these three salivary proteins (elicited individual protective efficacies between 27 % 429
and 44 % (table 1). These results indicate that O. moubata salivary anti-haemostatics are 430
suitable antigen candidates for the development of anti-tick vaccines that deserve further 431
studies (Diaz-Martín, 2014). 432
Overall, these results confirm that soft tick salivary antigens are able to induce 433
protective immune responses when administered individually. Such protection essentially 434
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consists of the partial inhibition of blood feeding and subsequent reduction in female fertility, 435
most likely as a consequence of the antibody-mediated loss of function of the target antigen at 436
the tick-host interface. 437
Although exploring additional adjuvants and immunization protocols would probably 438
increase the protective efficacies of these antigens, our opinion is  that a main factor limiting 439
the protection achieved with these vaccines (based on recombinant salivary antigens 440
administered individually) is the complexity, multiplicity and functional redundancy of tick 441
saliva composition, which would compensate the vaccine-mediated loss of function of the 442
target antigen with non-targeted salivary proteins exerting redundant functions (Chmelar et 443
al 2012 Kazimírová and Štibrániová 2013 Wikel 2013 Willadsen 2008) Hence the use of 444
vaccines formulated with several target antigens would likely increase the protective efficacy 445
of such vaccines. 446
In addition, the identification of the protective epitopes on those antigens would allow 447
the construction of chimeric recombinant antigens in order to simultaneously target 448
redundant anti-defensive mechanisms in ticks. Accordingly, the results described here could 449
serve as a starting point to search for protective epitopes in immunogenic proteins from 450
argasids (such as phospholipase A2, apyrase and mougrin) that have functional orthologues in 451
ixodids to identify similar or conserved protective epitopes. The identification and inclusion in 452
a chimeric recombinant antigen of such epitopes would offer the possibility of obtaining 453
broader-spectrum vaccines that could be useful for the control of a greater number of vectors 454
and by extension the pathogens they transmit (de la Fuente, 2012; Merino et al., 2013; Parizi 455
et al., 2012; Prudencio et al., 2010).  456
According to Sikic and Carugo (2010), the increasing potential of new computational 457
tools for selecting proteins with specific functions can aid in large-scale analyses for the 458
identification of potential new antigen targets for vaccines. This could also be applied to the 459
identification and designing of synthetic epitopes conserved in redundant protein families. 460
461
Future prospects and new strategies for the identification of novel protective antigens. 462
In his review on anti-tick vaccines, Willadsen (2008) analysed the three main types of 463
experimental approaches traditionally used for identifying useful vaccine antigens in ticks: i.e., 464
the immunological one, based on studying antigens that elicit an immune response; the 465
functional one based on identifying tick factors important for the parasite’s function and 466
survival and then evaluating them as potential vaccine antigens; and biochemical fractionation, 467
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based on evaluating progressively simpler protein mixtures by host vaccination and parasite 468
challenge trials. 469
Currently, the increasing availability of tick genomic, transcriptomic and proteomic 470
sequences in public data bases (namely: VectorBase, The Gene Index Project, CattleTickBase) 471
together with the development and application of new technologies of large-scale analysis 472
(NGS, RNAseq, microarrays, etc.) is driving the rapid transition from the above-mentioned 473
traditional approaches for protective antigen identification to new strategies based on reverse 474
vaccinology, which constitute a very important part of the emerging field of vaccinomics 475
(Aljamali et al., 2009a, 2009b; de la Fuente and Merino, 2013; Flower et al., 2010; Guerrero et 476
al., 2012; Manzano-Román et al., 2013; Maritz-Olivier et al., 2012; Oliveira et al., 2013; Ribeiro 477
and Arcá, 2009; Ribeiro et al., 2011, 2012). 478
These holistic approaches analyse the interactions between hosts, ticks and pathogens, 479
obtaining genomic, transcriptomic, proteomic, immunological and metabolic information 480
(systems biology) that is later integrated and analysed in silico to perform a theorical, 481
hypothesis-driven selection of candidate vaccine antigens (Nakaya et al., 2012; Six et al., 2012). 482
The resulting candidate antigen list can then be progressively reduced by carrying out 483
relatively simple and cost-effective experimental assays in order to select those with the 484
highest protective potential. One of these assays is the RNAi-mediated gene knockdown (de la 485
Fuente et al., 2010; Manzano-Román et al. 2012b, 2012c). In spite of its limitations, which 486
include the potential incongruity between RNAi loss of function phenotypes and vaccine 487
efficacy of the involved proteins in vivo (Nijhof et al., 2007), RNAi has demonstrated a great 488
potential in the context of screening genomic and transcriptomic data from arthropod 489
ectoparasites becoming an attractive post-genomic tool to inform the selection of vaccine 490
candidates (Marr et al., 2014). Selected candidates could then be obtained as recombinant 491
proteins and validated as protective antigens in animal vaccination trials, and their function 492
and protective mechanism could be characterized (de la Fuente and Merino, 2013) (Figure 1). 493
The application of these new strategies to soft ticks has just begun. The scant 494
transcriptomic and proteomic data currently available are limited to the salivary glands and/or  495
saliva of half a dozen species (Díaz-Martín et al., 2013a; Francischetti et al., 2009; Ribeiro et al., 496
2012) while no “omic” data from any other tissue or organ from soft ticks have been obtained 497
Some available comparative analyses of the soft and hard tick sialomes indicate that 498
the major families of salivary proteins are conserved between tick families encouraging the 499
search for conserved protective antigens (Mans et al., 2008). Obtaining and analysing sialomes 500
from more soft tick vectors will provide valuable data to identify new vaccine candidates 501
including potential dual-action antigens if proved that they are secreted into saliva and so that 502
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exposed to host in natural contact. Hence our group applied proteomics to study the saliva of 503
O. moubata unveiling notable differences in the saliva composition between females and 504
males as well as a high ratio of intracellular housekeeping proteins that were secreted to saliva 505
by non-classical ways, which significantly increased the expected range of salivary proteins 506
exposed to the host immune system during natural infestations (Diaz-Martín et al., 2013a). 507
Moreover, we developed Nucleic Acid Programmable Protein Arrays (NAPPA) from an O. 508
moubata salivary gland cDNA expression library to study protein interactions and functions in a 509
high-throughput format and cell-free system. As mentioned previously, the screening of these 510
microarrays allowed identifying some new salivary protective antigens (Manzano-Román et al., 511
2012b). 512
As highlighted in section 3, a number of current research programs are prioritizing the 513
identification of protective antigens that are expressed in the midgut membranes of hard ticks. 514
This should be also a priority for soft ticks but the absence of argasid genomes and argasid 515
midgut transcriptomes and proteomes is precluding the application of reverse vaccinology 516
strategies to the identification of intestinal protective antigens. Therefore, obtaining and 517
analysing midgut transcriptomes and proteomes from soft tick vectors is urgently needed. This 518
information will facilitate basic knowledge about the biology of these parasites and their 519
relationship with hosts and tick-borne pathogens. This information will also permit 520
comparisons to ixodid midgut transcriptomes and proteomes and probably the identification 521
of conserved antigens in both tick families allowing the selection of target antigens. The 522
combination of key midgut and salivary antigens will facilitate development of wide-range 523
highly effective vaccines for the control of ticks and the diseases they transmit.  524
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Figure Caption. 830
831
Figure 1. Reverse vaccinology approaches for the identification and validation of soft tick 832
protective antigens. When searching for suitable vaccine candidates a number of desirables 833
attributes might be taken into consideration. Currently, tick midgut and salivary glands are 834
being prioritized as the most appropriate sources of protective antigens. The transcriptomic, 835
proteomic and immunological data from the targeted organ or tissue are integrated and 836
analysed in silico performing a theorical selection of vaccine candidates. The resulting 837
candidate antigen list can be progressively reduced by applying experimental tools (i.e., RNAi) 838
that may inform on antigens with high protective potential. Selected candidates are obtained 839
as recombinant proteins and validated as protective antigens in animal vaccination trials.840
a, Salivary antigens from females are prioritized in order to target feeding (and fecundity) in 841
this developmental stage. 842
b, for midgut antigens, vaccine-derived deleterious effects can be independent of the antigen 843
function if the antigen acts as an anchor for host immune effectors such as antibodies and 844
complement (i.e., Bm86).845
846
847
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Table 1. Vaccine trials using concealed and salivary antigens from soft ticks.
Species Antigen name Protein identity Protein type
Protein 
function
Host PROTECTION REFERENCE
Concealed antigens
Argas polonicus LH - Larval homogenate - Pigeon
60% reduction in 
engorged larvae
Dusbábek et al., 
1990
Argas persicus DNA from eggs - - - Chicken
75% - 89% rejection of 
feeding ticks
Sayed et al., 2004
O. erraticus
Haemolymph -
Soluble fraction of 
tissue extracts
-
Pig No protection
Astigarraga et al., 
1995
Synganglion - -
Coxal glands - -
Midgut - -
GME -
Membrane proteins 
(insoluble fraction 
of midgut extract)
- Pig
80% reduction in
nymphs survival,
50% reduction in 
female feeding and 
fecundity 
Manzano-Román 
et al., 2006
GME -
Membrane proteins 
(insoluble fraction 
of midgut extract)
- Mouse
67% and 29% reduction 
in nymphs and larvae
survival, respectively
Manzano-Román 
et al., 2006
Oe45 Not determined
Native protein,
purified from 
midgut membranes
- Pig
21% - 27% reduction in
nymphs survival,
35% - 42% reduction in 
female feeding and  
fecundity
Manzano-Román 
et al., 2007
Table 1
rOeSub
O. erraticus
subolesin 
Recombinant
Transcription 
factor
Rabbit
22% reduction in 
oviposition Manzano-Román 
et al., 2012b
rOmSub
O. moubata
subolesin
Recombinant
Transcription 
factor
Rabbit
24.3 % reduction in 
oviposition
OE1
O. erraticus
subolesin  
Synthetic peptides
Transcription 
factor
Rabbit
49% reduction in 
fecundity
Manzano-Román 
et al., 2015
OE2
O. erraticus
subolesin  
82% reduction in  
fecundity
OM1 O. moubata
subolesin  
50% reduction in  
fecundity 
OM2 O. moubata
subolesin  
17% reduction in  
fecundity 
O. moubata
Egg yolk protein Vitellin Native 
Embryonic 
development
Rabbit
50% reduction in 
oviposition
Chinzei and 
Minoura, 1988
GME -
Membrane proteins 
(insoluble fraction 
of midgut extract)
-
Mouse,
rabbit,
pig
40% reduction in 
female feeding and 
reproduction
García-Varas, 2004
rOeSub
O. erraticus
subolesin 
Recombinant
Transcription 
factor
Rabbit
8.5 % reduction in 
oviposition Manzano-Román 
et al., 2012b
rOmSub
O. moubata
subolesin
Recombinant
Transcription 
factor
Rabbit
5.2 % reduction in 
oviposition
OE1
O. erraticus
subolesin  
Synthetic peptides
Transcription 
factor
Rabbit
35% reduction in 
fecundity 
Manzano-Román 
et al, 2015
OE2
O. erraticus
subolesin  
40% reduction in 
fecundity
OM1 O. moubata
subolesin  
45% reduction in 
fecundity
OM2 O. moubata
subolesin  
60% reduction in 
fecundity
O. talaje
Gut - Tissue extract - CD1 mouse
32% reduction in tick 
survival Need and Butler, 
1991Internal organs, 
not gut
- Tissue extract - CD1 mouse
27% reduction in tick 
survival
O. turicata
Gut - Tissue extract - CD1 mouse
No 
protection Need and Butler, 
1991Internal organs, 
not gut
- Tissue extract - CD1 mouse
No 
protection
Salivary antigens
Argas polonicus SGE -
Salivary gland 
extract
- Pigeon No protection
Dusbábek et al., 
1990
Argas persicus SGE -
Salivary gland 
extract
- Chicken
58% - 62% rejection of 
feeding ticks
Sayed et al., 2001
O. erraticus
SGE -
Salivary gland 
extract
- Pig
Variable, < 50%  
reduction in female 
feeding and fecundity
Astigarraga et al., 
1995
70 kDa antigen Not determined
Native, purified 
from SGE
Not determined Pig No protection
Manzano-Román, 
2002
50 kDa antigen Not determined
Native, purified 
from SGE
Not determined Pig No protection
20 kDa antigen Not determined
Native, purified 
from SGE
Not determined Pig
Up to 50%  reduction in 
female feeding and 
fecundity
O. moubata
SGE -
Salivary gland 
extract
- Pig
60% - 70 % reduction in 
female feeding and 
fecundity
Astigarraga et al., 
1995
Om44 - Native
P-selectin 
antagonist
Pig
54% reduction in tick
feeding,
50% reduction in 
García-Varas et al., 
2010
aVaccine efficacy (E) was calculated as E = 100 (1- S x F), where S and F respectively represent the reduction in female survival and fertility in ticks 
fed on vaccinated rabbits as compared to those fed on control rabbits (treated with the adjuvant only). 
female fecundity
OmC2 Cystatin Recombinant
Peptidase 
inhibitor
C3H/HeN 
mouse
39%  reduction in 
nymph-1 feeding,
15% increase in 
nymph-1 mortality
Salat et al., 2010
rOmENO Enolase Recombinant
Glycolytic 
enzyme
Rabbit
18% reduction in 
female fecundity,
20% increase in 
nymphal mortality
Díaz-Martín et al., 
2013
rOmPLA2 Phospholipase A2 Recombinant Anti-haemostatic Rabbit
23% reduction in 
female fertility, 
11% - 32% increase in 
tick mortality
(E = 44.2%)a
Díaz-Martín, 2014
rOmAPY Apyrase Recombinant
Anti-platelet 
aggregation
Rabbit
26% reduction in 
female fertility,
16% increase in adult 
mortality
(E = 27.2%)a
rOmMOU Mougrin Recombinant disaggregin Rabbit
32% reduction in 
female fecundity
(E = 43.2%)a
O. talaje SGE -
Salivary gland 
extract
-
CD1
mouse
19% reduction in
larvae survival
Need and Butler, 
1991
